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ABSTRACT 
 
Aims: This study was aimed at evaluating the potential leukaemia chemotherapeutic activities of 
various extracts of Kigelia africana stem bark; fruit and leaf by using a benzene-induced model of 
leukaemia to validate its folkloric use. Evidences from African herbal medicine and traditional 
applications have shown that Kigelia africana plant has several beneficial therapeutic properties 
against microbial infections and cancer cell lines. 
Study Design: Experimental study. 
Original Research Article 
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Place and Duration of Study: Department of Biomedical Science, College of Health Sciences, 
Ladoke Akintola University of Technology, Osogbo, Nigeria and study was conducted between 
August, 2016 and November, 2016. 
Methodology: Rats were administered 0.2 mL of benzene solution intravenously through the tail 
48-hourly for 4 weeks, tested periodically and observed till leukaemia developed prior to treatment 
with respective extract of the Kigelia africana stem bark, fruit and leaf in appropriate rat groups after 
leukaemia was confirmed with haematological protocols. Leukaemic rats were administered with 
100 mg/mL contained in 0.5 mL stem bark, 0.5 mL fruit and 0.2 mL of the leaf extract orally by 
gavage using oral cannula once daily post leukemia induction for four weeks. Haematological 
parameters and white blood cells differential counts (lymphocytes) were assessed in both control 
and treatment groups to determine the leukaemia burden. 
Results: Kigelia africana treatment using the stem bark, fruit and leaf significantly (P < 0.05) 
alleviated the anaemia indices and reduced the marked leucocytosis usually associated with 
leukaemia toward the negative control level when compared with the leukaemia control group. 
Antileukaemic activity however appears to be highest in stem bark, and least in the leaf. 
Conclusion: This study revealed the potential of ethanol extracts of Kigelia africana stem bark, fruit 
and leaf to reverse leukaemic effects in benzene-induced leukaemia bearing wistar rats and this 
suggest that the extracts might be promising natural, non-toxic and anticancer agents. 
 
 
Keywords: Kigelia africana; benzene; cancer; chemotherapy; leukaemia; chemoprevention. 
 
1. INTRODUCTION 
 
The incidence of deadly diseases globally is 
alarming, which has geared a number of 
scientists into research and experiment on 
various causes of these diseases. One of the 
deadliest diseases currently ravaging and killing 
humans and even animals is cancer [1]. Cancer 
is a broad group of various diseases involving 
unregulated abnormal cells growth anywhere in 
the body and develops in almost any organ or 
tissue and it occurs in many forms of over 200 
different types [1]. Leukaemia has been 
described as a cancer of the blood or bone 
marrow affecting haemopoietic stem cell 
compartment, characterised by uncontrolled 
proliferation and accumulation of malignant 
leukocytes in the bone marrow and peripheral 
blood usually results from somatic mutations in 
the DNA [2]. Some mutations trigger this 
haematological malignancy by activating 
oncogenes or deactivating tumour suppressor 
genes consequently disrupting the regulation of 
cell death or differentiation. These mutations 
found even within the African continent and 
beyond, may occur spontaneously or could result 
from exposure to radiation or carcinogens such 
as benzene [3]. 
 
Cancer treatment with the aid of chemotherapy 
and radiotherapy have not been fully maximized 
in patients because of their numerous severe 
side-effects and toxicity, while the use of several 
anticancer agents derived from plants are being 
employed in clinical use all around the globe 
without harming the normal cells of the body      
[4,5]. Herbal medicines play a vital role in the 
prevention and treatment of cancer and are 
commonly available and comparatively 
economical. Many of these medicinal herbs are 
presently being investigated for novel drugs or 
templates for the development of new 
therapeutic agents [6,7]. 
 
Kigelia africana (Lam.) Benth is a tropical African 
plant found on riverbanks, where it may reach 
20m, along streams and on flood plains, also in 
open woodland, from KwaZulu-Natal to Tanzania 
[8]. The plant is widely grown and distributed in 
South, Central and West Africa belonging to the 
family of Bignoniaceae and commonly called the 
"Sausage tree" because of its huge fruits. The 
African common names include the ‘pandoro' 
(Yoruba), ‘uturubien' (Ibo) and ‘Hantsar giiwaa' 
(Hausa) [9]. It is widely grown as an ornamental 
plant in tropical regions for its decorative flowers 
and used throughout Africa, India and the Middle 
East whereby the tree has been widely cultivated 
as an endemic species in different habitats for its 
various medicinal purposes [10,11]. The 
preparations of Kigelia africana have been 
shown to possess antimicrobial effects [12] and 
have cytotoxicity against certain cancer cell lines 
[13,14]. Other reported ethno-medical uses of 
this plant include antioxidant activities [15]. 
Literature on the chemical composition of Kigelia 
africana via bioactivity-guided fractionation has 
revealed that the extracts contain various 
cytotoxic agents, such as lapachol (regarded as 
a potential anti-cancer drug) [16], norviburtinal 
[13], kigelinone, and γ-sitosterol [17] among 
others. This study, therefore, investigated the 
chemotherapeutic effects of various ethanol 
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extracts of Kigelia africana stem bark, fruit and 
leaf respectively on benzene-induced 
experimental model of leukaemia in rats using 
some haematological indices as measuring 
indicators. 
 
2. MATERIALS AND METHODS 
 
2.1 Plant Material and Extract Preparation 
 
Fresh stem barks, fruits and leaves of Kigelia 
africana were collected from Kajola farm 
settlement, Ejigbo Local Government Area, Osun 
State. The plant with the selected parts were 
identified at the Botany Department, Obafemi 
Awolowo University and later authenticated at 
the Department of Pharmacognosy, Obafemi 
Awolowo University, Ile-Ife, Osun State. The 
stem bark was oven dried and coarsely 
powdered, the leaves were air dried and 
powdered. The fruits were washed, sliced into 
smaller pieces, oven dried at 40°C and coarsely 
powdered. 500 g of the plant parts were 
separately soaked in 1.5 litres of ethanol for 72 
hours using the cold soaking/maceration 
technique and then filtered using Whatman No.1 
filter paper. The filtrates were concentrated using 
rotary evaporator (Stuart Rotary Evaporator 
model RE:300) with the Kigelia africana bark 
(KAB) yielding 25.2 g (5.04%), Kigelia africana 
fruit (KAF) yielded 40.8 g (8.1%) and Kigelia 
africana leaf (KAL) yielded 30 g (5.8%). They 
were then stored at refrigerator temperature (2-
6°C) until used. 
 
2.2 Animals and Experimental Protocol 
 
Ninety-six Wister strain rats weighing between 
150 g and 200 g were purchased from the animal 
house of Ladoke Akintola University of 
Technology (LAUTECH), Osogbo Campus, 
Nigeria and utilized for this research. The rats 
were randomized into four groups consisting of 
eight animals per group of two replicates of four 
for each of the different plant extracts (32 rats 
per extract of the plant) and subjected to 
standard 12 hour light/dark cycle. Animals were 
housed in cages and provided water and feed ad 
libitum. The rats were allowed to acclimatize for 
seven days before the commencement of the 
experiment and the animals' room temperature 
was maintained at 28±2°C. Rats were randomly 
grouped according to the treatment received and 
were examined to be free of wounds, swellings 
and infections before the commencement of the 
experiment. All experimental protocols were 
conducted in compliance with the National 
Institute of Health Guide for Care and Use of 
Laboratory Animals. 
2.3 Administration of Benzene Solution 
 
The Benzene solution used with Cat No 270709 
and >99.9%  was purchased from sigma Aldrich 
GmBH (Steinheim, Germany) and diluted in 
water for injection at a concentration of 1mL of 
the benzene to 9 mLs of water for injection. 
Precisely 0.2 mL was administered intravenously 
through the tail every two days for four weeks. 
The young rats administered with benzene were 
allowed to grow under observation and tested 
periodically until leukaemia developed in 
significant number of them which were  
separated for further experimental treatment 
protocol. 
 
2.4 Acute Toxicity of Kigelia africana in 
Mice 
 
The acute toxicity study of Kigelia africana was 
determined according to the method of 
Sawadogo and colleagues [18]. Forty eight mice 
were fasted for 16 hours and randomly divided 
into eight groups of six animals each. Graded 
doses (100, 400, 800, 1600, 3200, and 6400 
mg/kg) of the ethanolic extract of Kigelia africana 
stem bark, fruit and leaves respectively 
corresponding to groups II, III,IV,V,VI and VII 
were separately administered to the mice in each 
test group by means of an oral cannula. The 
control group representing group I was 
administered with distilled water (10 mg/kg) only. 
All animals were then allowed free access to 
feed and water and observed for a period of 48 
hrs for signs of acute toxicity, morbidity and 
mortality.  
 
2.5 Administration of the Plant Extract 
 
Ninety-six rats were randomized into groups, 
consisting of eight animals in each group.  Group 
A; leukaemia control rats were administered 
benzene (0.2 mL) 48-hourly for four weeks. 
Groups B received commercial feed with water 
only, C received Benzene and treatment with 
ethanol extract of K. africana for 3 weeks daily, 
and D received ethanol extract of K. africana 
plant with commercial diet only (different extracts 
of K.africana stem barks, K. africana fruits and 
K.africana leaves) respectively. The ethanol 
extracts of the various K. africana plant was 
administered by gavage once daily with                        
the aid of oral cannula; the dose administered                
to the appropriate experimental rats was                 
0.5 mL of 100 mg/mL stem bark, 0.5 mL fruit and 
0.2 mL of the leaf extract for 3 weeks 
respectively. 
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Table 1. Experimental protocol 
 
Group Treatment Inference 
A (n=8) Leukaemia induction with benzene only Leukaemia positive control  
B (n=8) Commercial feed with water only Leukaemia negative control 
C (n=8) Leukaemia induction with Benzene and treatment with 
Ethanol extract of *K. africana plant for 3 weeks daily 
Chemotherapeutic effect 
D (n=8) Ethanol extract of *K. africana plant with commercial diet 
only 
Adverse reaction / toxicity 
*Ethanol extracts of K. africana stem bark, fruit and leaves were investigated separately using the same protocol 
in 2 replicates each 
 
2.6 Sample Preparation 
 
The rats were sacrificed 12 hours after the 
conclusion of the experiment under light ether 
anesthesia by cervical dislocation. The blood 
samples were collected from the inferior vena 
cava by the use of 5 mL syringe and dispensed 
into ethylene diamine tetra acetic acid (EDTA) 
vials, gently mixed and labeled appropriately. 
 
2.7 Determination of Haematological 
Parameters 
 
Haematological parameters and indices were 
evaluated by flow cytometry (direct current 
method) using auto-analyzer Outra O SH800-
Plus with the aid of suitable cell packs as 
described by Akinbo et al. [19]. Differential WBC 
count was also conducted to complement the 
automation estimation result using Leishman 
staining technique as previously described by 
Bain and Lewis [20]. 
 
2.8 Statistical Analysis 
 
Data were expressed as mean ± S.D of two 
replicates in each group. Analysis of variance 
(ANOVA) and paired t-test were carried out to 
test for the level of extract efficacy at p <0.05 
among the groups using the statistical package 
for social sciences (SPSS) 21.0 versions. 
 
3. RESULTS 
 
3.1 LD50/Acute Toxicity Determination 
 
The oral administration of graded doses (100, 
400, 800, 1600, 3200 and 6400 mg/kg) of the 
ethanol extracts of K. africana to mice did not 
produce any significant changes in behaviour, 
breathing or gastrointestinal effects during the 
observation period. Also, no deaths were 
recorded at any point in this study. The LD50 of 
the different parts of Kigelia africana is therefore 
greater than 6400 mg/kg orally in mice. 
Haematological parameters such as haematocrit 
(HCT), total white blood Cell (WBC), red blood 
cell (RBC), haemoglobin (HGB), platelets (PLT), 
and red cell indices such as mean cell volume 
(MCV), mean cell haemoglobin (MCH) and mean 
cell haemoglobin concentration (MCHC) were 
assessed in the whole blood of experimental rats 
(Figs. 1-3). Results of the haematological 
parameters being the major leukaemic indices in 
the various experimental groups are shown in 
Table 2. There was marked reduction in the 
HCT, RBC, HGB and PLT in group A (Leukaemia 
Positive Control) while the WBC count was 
markedly increased when compared to other 
groups indicative of a successful leukaemia 
development (Figs. 1 and 2). 
 
The RBC indices were significantly (p<0.05) 
increased in the treatment groups than the 
leukaemia positive control group. K. africana 
treatment of the appropriate groups resulted in 
significant (p<0.05) reduction in the WBC count 
suggestive of the reversal and alleviation of the 
leukaemia induction in the treatment group 
(Table 2). 
 
There were significant (p<0.05) differences in all 
the haematological parameters evaluated in 
group B (Commercial feed with water only)  when 
compared with A (leukemia induction/positive 
control) showing significantly elevated leukocyte 
count and reduced haemoglobin, and packed 
cells volume in the leukaemia positive group 
except in platelets and MCV. This confirms that 
the administered benzene actually induced 
leukemia in the rats. 
 
Treatment of the healthy rats with all the different 
ethanol extracts of K. africana alongside 
commercial diet alone (group D) exhibited no 
significant (p>0.05) variation in the evaluated 
haematological indices when compared with the 
healthy rats in group B that received commercial 
feed and water only (Table 2). This revealed that 
there was no adverse reaction or toxicity 
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experienced by the rats as a result of 
administration of the various ethanol extracts. 
The estimated parameters in group B served as 
reference values. 
 
 
 
Fig. 1. Some haematological parameters of the respective groups of experimental rats  
Bars represent mean ± SEM (n=8). Bars with different statistical markers are significantly different at p <0.05 
 
 
 
Fig. 2. Typical haematological indices of the respective groups of experimental rats  
Bars represent mean ± SEM (n=8). Bars with different statistical markers are significantly different at p <0.05 
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Table 2. Haematological parameters in the various treatment rat groups using the different extracts of K. africana plant 
 
Extract Group HCT (%) WBC (10
9
/L) RBC (10
12
/L) 
 
HGB  
(g/dL) 
PLT (10
5
/µL) MCV (fl) MCH (pg) MCHC (g/dL) 
KASB A 31.88±2.59 11.08±0.31 4.52±0.39 6.68±0.96 3.90±1.46 70.70±5.48 14.67±1.09 20.92±2.03 
KASB B 43.74±1.72* 6.84±0.30* 6.30±0.39* 13.62±0.69* 5.19±0.42 69.24±2.50 20.62±1.56* 31.22±1.64* 
KASB C 41.28±9.48 6.92±0.97* 5.94±1.17 12.90±4.45 5.19±0.42 69.24±2.50 19.80±4.45 30.14±5.15* 
KASB D 41.48±3.78* 6.77±0.22* 5.96±0.48* 12.00±2.26* 5.96±0.48 69.53±1.19 19.02±2.34* 28.75±3.29* 
KAF A 31.88±2.59 11.08±0.31 4.52±0.39 6.68±0.96 3.90±1.46 70.70±5.48 14.67±1.09 20.92±2.03 
KAF B 43.74±1.72* 6.84±0.30* 6.30±0.39* 13.62±0.69* 5.19±0.42 69.24±2.50 20.62±1.56* 31.22±1.64* 
KAF C 39.04±7.37 7.40±1.01 5.57±1.01 9.54±4.07 5.13±1.43 69.24±2.50 19.80±4.45 30.14±5.15* 
KAF D 46.88±6.27* 6.77±0.22* 6.68±0.48* 13.43±3.07* 5.46±1.48 69.53±1.19 19.02±2.34* 28.75±3.29* 
KAL A 31.88±2.59 11.08±0.31 4.52±0.39 6.68±0.96 3.90±1.46 70.70±5.48 14.67±1.09 20.92±2.03 
KAL B 43.74±1.72* 6.84±0.30* 6.30±0.39* 13.62±0.69* 5.19±0.42 69.24±2.50 20.62±1.56* 31.22±1.64* 
KAL C 42.02±1.18 6.70±0.55 5.93±0.56 12.18±2.91 4.71±0.29 71.78±2.92 19.34±2.80 30.14±5.15* 
KAL D 40.12±3.27* 6.98±0.18* 5.70±1.81* 13.78±1.29 4.65±0.97 68.36±4.68 18.84±3.79* 28.75±3.29* 
Results are expressed as Mean ± S.D. KASB = Kigelia africana stem bark, KAL = Kigelia africana leaves, KAF = Kigelia africana fruit. 
** Indicates significant difference at p<0.05 
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Fig. 3. Haematocrit and haemoglobin levels of the respective groups of experimental rats  
Bars represent mean ± SEM (n=8). Bars with different statistical markers are significantly different at p <0.05 
 
4. DISCUSSION 
 
The modulating effect of the different ethanol 
extract of K. africana plant on some basic 
haematological parameters was analyzed by 
assessing circulating levels of total WBC counts, 
PCV/HCT, platelets count, red blood cell counts, 
haemoglobin and haematological indices in the 
peripheral blood of control and treatment groups. 
Anaemia of chronic disease was observed in rat 
groups where leukaemia was induced due to 
exposure to benzene solution which is a potent 
carcinogen. This anaemia is evident by the 
significant (P<0.05) reduction in HCT, HGB and 
red cell counts observed in rats in group A when 
compared with group B (reference value). 
Anaemia and thrombocytopaenia are considered 
some of the classical pointers of leukaemia and 
other haematological malignancies [21]. These 
established the successful induction of 
leukaemia in the appropriate groups especially 
the positive control group. The reversal of these 
major anaemia indices in the K. africana - treated 
groups suggests that this extract has the ability 
to enhance the erythropoietic activities in animal 
models with leukemia and subsequently 
ameliorating the condition. This study represents 
an outcome of the in-vivo activity of the ethanol 
extract of K. africana stem barks, fruits and 
leaves. 
Benzene-induced rat leukaemia are a suitable 
experimental animal model for evaluating the 
anti-leukaemic effect of natural products and are 
believed to be predominantly mediated via 
metabolites such as benzene oxide [22]. The 
central chain of events in the leukaemia-
induction concept is based on the idea of marked 
leukocytosis precipitated by the reactive 
metabolites of benzene being able to mutate a 
critical gene or set of genes related to 
proliferation and differentiation in human stem 
cells resulting in chromosomal aberrations 
(aneuploidy, translocations, inversions, and 
deletions), aberrant mitotic recombination, gene 
mutations, and/or epigenetic alterations [23]. This 
was observed in the groups of leukemia-induced 
rats as reported also in other previous works 
[24,25]. The leukaemia-positive control groups 
(benzene treated only) in this study showed 
significantly higher total WBC count than the 
negative control (P < 0.05) and treatment groups 
correlating with the studies listed above. 
Evidently, the K. africana-treated groups showed 
a significant reduction in the total WBC count 
evidence of the extract activity. This is consistent 
with the findings of other previous investigators 
[13], where they discovered the crude 
dichloromethane extracts of stem bark and fruit 
of the plant showed cytotoxic activity in vitro 
against cultured melanoma and other cancer cell 
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lines using the Sulphorhodamine B assay, which 
was employed for bioassay-guided fractionation. 
The in vitro cytotoxic activity found in root bark 
extract of K. africana has been attributed to a few 
of its metabolic compounds most commonly γ-
sitosterol which is comparable to standard, 
lapachol [26]. These results substantiate                
and support the use of the K. africana plant 
extracts as a potent cytotoxic or anticancer 
agent. 
 
This study showed progressive improvement in 
the values of HCT, HGB, PLT, MCV, RBC and 
MCH of the treatment groups when compared to 
the leukaemia positive control group. This is 
indicative of the chemotherapeutic activity of the 
ethanol extract of the plant against leukaemia 
and is similar to the results obtained in an earlier 
study where the effect of Kigelia africana and 5-
Fluorouracil on the body weight of tumor-bearing 
mice was assessed which showed that the pure 
compound of Kigelia africana exhibited 
significant anticancer activity when compared 
with the standard anti-cancerous drug [27,28]. 
This finding correlates with other previous 
studies on plant derived anti-leukaemia treatment 
which revealed the cytotoxicity of ethanol 
fractions of Moringa oleifera on acute 
myelogenous leukaemia cell culture [29]. The 
extracts of the plant have been shown to 
possess various potential anticancer agents [30, 
31]. The anti-leukaemic activity however appears 
to be highest in the plant stems bark, and least in 
the leaf. 
 
Further comparison of the K. africana treatment 
groups with the leukaemia negative control group 
showed that there were no significant (P˃0.05) 
differences in the haematological parameters. 
Similarly, when rats that were administered with 
the different ethanol extracts of K. africana 
(group D) were compared with groups fed with 
commercial feed and water only (group B) there 
was no significant (P˃0.05) difference in the 
haematological parameters. This was an 
indication of the tolerable nature of the bioactive 
components of the plant extract on the animals 
[32,33]. This finding indicates that the ethanol 
extract of K. africana has no toxic effect on the 
red blood cell parameters i.e. red blood cell 
count, haemoglobin concentration, packed cell 
volume, mean corpuscular volume, mean 
corpuscular haemoglobin concentration and 
mean corpuscular hemoglobin; also that the 
administration of K. africana plant extract to rats 
does not produce any deleterious effects on red 
blood cells and haemoglobin. Therefore, the 
ethanol extract of K. africana has no adverse or 
toxic effects on healthy haemopoietic cells. 
 
5. CONCLUSION 
 
This study, therefore, shows that ethanol extract 
of K. africana stem barks, fruits and leaves 
possess anti-leukaemic properties as reflected 
on benzene-induced leukaemia in Wister rats 
and thereby mitigating the associated anaemia of 
chronic disease and thrombocytopaenia when 
administered orally to rats after exposure to 
benzene. In the future, phytochemical screening 
and characterization of the extracts of the various 
plant parts would help determine its bioactive 
components as our study suggests that the 
extract might be a promising natural, non-toxic 
anticancer agent. 
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